je.st
news
Tag: design tools
TSMC Certifies Mentor Graphics Tools for Early Design Start in TSMC's 10nm FinFET Technology
2015-04-09 12:31:14| Industrial Newsroom - All News for Today
WILSONVILLE, Ore. - Mentor Graphics Corp. (NASDAQ: MENT) today announced that TSMC and Mentor Graphics have reached the first milestone of their collaboration on 10nm EDA certification. Calibre physical verification and design for manufacturing (DFM) platform, and the Analog FastSPICE (AFS) Circuit Verification...
Tags: start
design
tools
technology
TSMC Certifies Synopsys Design Tools for 16-nm FinFET Plus Production and for 10-nm Early Design Starts
2015-04-09 12:31:14| Industrial Newsroom - All News for Today
Synopsys Tools are 16-nm-Certified and Deployed in Production Designs; 10-nm Co-development Enables Engagements with Early Adopters MOUNTAIN VIEW, Calif. - Highlights: -- Certification includes the full suite of digital, signoff and custom implementation tools -- IC Compiler certification...
Tags: design
tools
early
production
Ford Pushes Interior Design Forward, Testing Innovative Research Tools
2015-03-19 21:55:34| Automakers - Topix.net
Ford is working with new research and measurement methods and high-tech tools to collect emotional and logical customer insights and learn more about how people visually discover new cars and trucks. New techniques include eye tracking, measuring where eyesight lingers most and biometrics.
Tags: design
tools
research
forward
Keysight Technologies to Demonstrate Latest EMC Design, Test Tools at EMCSI Symposium
2015-03-17 11:31:13| Industrial Newsroom - All News for Today
SANTA ROSA, Calif. -- Keysight Technologies, Inc. (NYSE: KEYS) today announced it will demonstrate and discuss the latest tools and techniques on 1) EMC design and testing, and 2) signal and power integrity at the EMCSI 2015 Symposium, Santa Clara Convention Center, Booth 618, March 17-19. Keysight will have EMC...
Tags: design
tools
test
latest
Tools for the Design of Vaccines to Help Reduce Clinical Failure
2014-09-11 16:23:44| drugdiscoveryonline Home Page
If you are involved in the pharma industry, then you are interested in saving lives. In the area of preventative medicine, therapeutic vaccines have proven to have a tremendous impact on the ability to save millions of lives. Similar to pharmaceuticals, vaccine development can take over 10 years and less than 10 percent of candidates reach commercialization. Reducing the cost of failure and increasing the chances of clinical success for vaccines is beneficial to both the pharma industry and those being treated for or protected from disease. Dr. Noel Smith, Senior Group Leader, Lonza Biologics Lonza understands this need and how ensuring the design and development of efficacious vaccines is critical for worldwide health. To address this, Dr. Noel Smith, Senior Group Leader, and the Applied Protein Services team at Lonza launched the Epibase™ Platform of in silico and in vitro immunogenicity screening services to help increase the chances of success for anyone aiming to develop safe and potent vaccines. “Our tools help researchers in the discovery stage of vaccine design and development to optimize their molecules before they progress into manufacturing for clinical trials,” says Dr. Smith. “Early assessment and optimization of immune responses allows you to focus your R&D resources on a smaller number of vaccine candidates with the greatest chance of success.”
Tags: design
tools
reduce
failure